Accretion Nutraveda Ltd (544694) — Board Meeting | 1 September 2026
Accretion Nutraveda's board approved amendments to its Memorandum of Association to expand business scope into nutraceuticals, pharmaceuticals, and healthcare services, including new sub-clauses for financial activities and investments. The changes require shareholder approval via postal ballot under the Companies Act and SEBI regulations. The filing emphasizes regulatory compliance for operational flexibility in new markets.
About Accretion Nutraveda Ltd (544694)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 544694 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 544694 — Free💡 Ask AI about this filing
📊 More 544694 filings
- 🟡 Board Meeting — 27 August 2026 Accretion Nutraveda held its 5th AGM on 27 August 2026 via video conference, adopting 2026 audited f...
- 🟡 Voting Results — 27 August 2026 Accretion Nutraveda shareholders approved all 10 AGM resolutions via remote e-voting and in-person p...
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd